Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bellamy

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Rheumatology|March 1, 1992
Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trialsN Bellamy, S Carette, P M Ford, et al.
The Journal of Rheumatology|June 1, 1993
A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the kneeN Bellamy, W W Buchanan, A Chalmers, et al.
The Journal of Rheumatology|March 1, 1992
Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exerciseN Bellamy, S Carette, P M Ford, et al.
Inflammopharmacology|July 4, 2008
An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for ankylosing spondylitisN Bellamy, C Anjema, D Dhanoa, et al.
Inflammopharmacology|January 1, 1997
Fibromyalgia antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent outcome measuresN Bellamy, R Buchbinder, S Hall, et al.
Current Medical Research and Opinion|January 1, 1992
Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trialN Bellamy, A Beaulieu, C Bombardier, et al.
Annals of the Rheumatic Diseases|November 27, 2004
Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritisN Bellamy, M J Bell, C H Goldsmith, et al.
The Journal of Rheumatology|July 1, 1995
Variability of skin scores and clinical measurements in sclerodermaJ E Pope, M Baron, N Bellamy, et al.
The Journal of Rheumatology|November 1, 1991
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trialsN Bellamy, W W Buchanan, J M Esdaile, et al.
The Journal of Rheumatology|November 1, 1991
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exerciseN Bellamy, W W Buchanan, J M Esdaile, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|March 1, 1992
Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trialsN Bellamy, S Carette, P M Ford, et al.
The Journal of Rheumatology|June 1, 1993
A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the kneeN Bellamy, W W Buchanan, A Chalmers, et al.
The Journal of Rheumatology|March 1, 1992
Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exerciseN Bellamy, S Carette, P M Ford, et al.
Inflammopharmacology|July 4, 2008
An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for ankylosing spondylitisN Bellamy, C Anjema, D Dhanoa, et al.
Inflammopharmacology|January 1, 1997
Fibromyalgia antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent outcome measuresN Bellamy, R Buchbinder, S Hall, et al.
Current Medical Research and Opinion|January 1, 1992
Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trialN Bellamy, A Beaulieu, C Bombardier, et al.
Annals of the Rheumatic Diseases|November 27, 2004
Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritisN Bellamy, M J Bell, C H Goldsmith, et al.
The Journal of Rheumatology|July 1, 1995
Variability of skin scores and clinical measurements in sclerodermaJ E Pope, M Baron, N Bellamy, et al.
The Journal of Rheumatology|November 1, 1991
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trialsN Bellamy, W W Buchanan, J M Esdaile, et al.
The Journal of Rheumatology|November 1, 1991
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exerciseN Bellamy, W W Buchanan, J M Esdaile, et al.
Pageof 16